| Identification | Back Directory | [Name]
L 697661 | [CAS]
135525-78-9 | [Synonyms]
661
L 697661
L697661,L 697661
3-(4,7-Dichlorobenzoxazole-2-ylmethylamino)-5-ethyl-6-methyl-2(1H)-pyridinone
3-[(4,7-Dichlorobenzoxazole-2-ylmethyl)amino]-5-ethyl-6-methylpyridine-2(1H)-one
3-[[(4,7-Dichlorobenzoxazol-2-yl)methyl]amino]-5-ethyl-6-methylpyridin-2(1H)-one
5-Ethyl-6-methyl-3-[[(4,7-dichlorobenzoxazol-2-yl)methyl]amino]pyridin-2(1H)-one | [Molecular Formula]
C16H15Cl2N3O2 | [MDL Number]
MFCD00903736 | [MOL File]
135525-78-9.mol | [Molecular Weight]
352.22 |
| Chemical Properties | Back Directory | [Boiling point ]
558.568±50.00 °C(Press: 760.00 Torr)(predicted) | [density ]
1.420±0.10 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | [pka]
13.410±0.10(predicted) |
| Hazard Information | Back Directory | [Uses]
L 697661 is an orally active HIV-1 reverse transcriptase inhibitor[1]. | [References]
[1] Saag MS, et al. A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group. N Engl J Med. 1993 Oct 7;329(15):1065-72. DOI:10.1056/NEJM199310073291502 |
|
|